Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Notice of Meeting, 36806-36807 [2017-16520]
Download as PDF
<![CDATA[
36806
Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices
use by the Secretary of the U.S.
Department of Health and Human
Services or a designated representative
in the development of Healthy People
2030.
The Committee will meet on
September 6, 2017, from 8:30 a.m. to
5:00 p.m. Eastern Time (ET), and
September 7, 2017, from 8:30 a.m. to
2:30 p.m. ET.
ADDRESSES: The meeting will be held at
the 20 F Street NW. Conference Center,
located at 20th F Street NW.,
Washington, DC 20001. To register to
attend the meeting or deliver oral public
testimony, please visit the Healthy
People Web site at https://
www.healthypeople.gov.
DATES:
mstockstill on DSK30JT082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Emmeline Ochiai, Designated Federal
Officer, Secretary’s Advisory Committee
on National Health Promotion and
Disease Prevention Objectives for 2030,
U.S. Department of Health and Human
Services, Office of the Assistant
Secretary for Health, Office of Disease
Prevention and Health Promotion, 1101
Wootton Parkway, Rm. LL–100,
Rockville, MD 20852, (240) 453–8280
(telephone), (240) 453–8281 (fax).
Additional information is available on
the Healthy People Web site at https://
www.healthypeople.gov.
SUPPLEMENTARY INFORMATION:
Appointed Committee Members: The
names and biographies of the appointed
Committee members are available at
https://www.healthypeople.gov/2020/
about/history-development/healthypeople-2030-advisory-committee.
Purpose of Meeting: In accordance
with Federal Advisory Committee Act
and to promote transparency of the
process, deliberations of the Committee
will occur in a public forum. At this
meeting, the Committee will continue
its deliberations from the last public
meeting.
Background: The Committee, a federal
advisory committee, is charged with
issuing recommendations for the
Secretary regarding the development
and implementation of national health
promotion and disease prevention
objectives for 2030. The Committee will
discuss the nation’s health promotion
and disease prevention objectives and
will provide recommendations to
improve health status and reduce health
risks for the nation by the year 2030.
The Committee will develop
recommendations regarding the criteria
for identifying a more focused set of
measurable, nationally representative
objectives for improving the health of
the nation by the year 2030 and
recommendations for engaging
VerDate Sep<11>2014
18:14 Aug 04, 2017
Jkt 241001
stakeholders in the implementation and
achievement of the objectives. The
Committee’s advice must assist the
Secretary in reducing the number of
objectives, while ensuring that the
selection criteria identifies the most
critical public health issues that are
high-impact priorities supported by
current national data. Through the
Healthy People initiative, HHS leverages
scientific insights and lessons from the
past decade, along with new knowledge
of current data, trends, and innovations,
to develop the next iteration of national
health promotion and disease
prevention objectives. Healthy People
provides science-based, 10-year national
objectives for promoting health and
preventing disease. Since 1979, Healthy
People has set and monitored national
health objectives that meet a broad
range of health needs, encourage
collaboration across sectors, guide
individuals toward making informed
health decisions, and measure the
impact of our prevention and health
promotion activities. Healthy People
2030 health objectives will reflect
assessments of major risks to health and
wellness, changing public health
priorities, and emerging technologies
related to our nation’s health
preparedness and prevention.
Meeting Agenda: The meeting agenda
will include (a) opportunity for the
public to give oral testimony, (b) review
of Committee work since the last public
meeting, and (c) plans for future
Committee work.
Public Participation at Meeting:
Members of the public are invited to
attend the Committee meeting. To
attend the Committee meeting,
individuals must pre-register at the
Healthy People Web site at https://
www.healthypeople.gov. Registrations
must be completed by 5:00 p.m. ET on
September 1, 2017. Space for the
meeting is limited and registration will
be accepted until maximum room
capacity is reached. A waiting list will
be maintained should registrations
exceed room capacity. Individuals on
the waiting list will be contacted as
additional space for the meeting
becomes available. Registration
questions may be directed to: Jim
Nakayama at events@
nakamotogroup.com, or (240) 672–4011.
Public Comments and Meeting
Documents: An opportunity to present
to the Committee oral comments
regarding the proposed Healthy People
2030 vision, mission, overarching goals,
foundational principles, and plan of
action will be provided at this meeting.
Those wishing to present oral comment
must pre-register at the Healthy People
Web site at www.healthypeople.gov by
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
5:00 p.m. ET, on August 21, 2017, and
must submit a written copy of their oral
testimony by 5:00 p.m. ET, on August
30, 2017, to Jim Nakayama at events@
nakamotogroup.com. The opportunity
to deliver oral testimony is limited.
Those presenting oral comments will
have two (2) minutes to address the
Committee. Guidelines for public
comment submissions can be viewed at
https://www.healthypeople.gov/2020/
About-Healthy-People/DevelopmentHealthy-People-2030/Public-Comment.
Written public comments can be
submitted and/or viewed at https://
www.healthypeople.gov/2020/AboutHealthy-People/Development-HealthyPeople-2030/Public-Comment/Items-forcomment. Documents pertaining to
Committee deliberations, including
meeting agendas and summaries are
available at https://
www.healthypeople.gov/2020/AboutHealthy-People/Development-HealthyPeople-2030/Committee-Meetings.
Questions regarding public comment
may be directed to: Jim Nakayama at
events@nakamotogroup.com or (240)
672–4011.
Authority: 42 U.S.C. 217a. The
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030 is
governed by provisions of the Federal
Advisory Committee Act (FACA), Public
Law 92–463, as amended (5 U.S.C.,
App.) which sets forth standards for the
formation and use of federal advisory
committees.
Dated: August 2, 2017.
Don Wright,
Deputy Assistant Secretary for Health
(Disease Prevention and Health Promotion).
[FR Doc. 2017–16608 Filed 8–4–17; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD); Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Child
Health and Human Development
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available. A
portion of this meeting will be closed to
the public in accordance with the
provisions set forth in sections
E:\FR\FM\07AUN1.SGM
07AUN1
Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices
mstockstill on DSK30JT082PROD with NOTICES
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review and
discussion of grant applications.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting.
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: September 14, 2017.
Open: September 14, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: The agenda will include opening
remarks, administrative matters, Director’s
Report, Division of Extramural Research
Report and, other business of the Council.
Place: National Institutes of Health,
Building 31, C-Wing, Conference Room 6,
9000 Rockville Pike, Bethesda, MD 20892.
Closed: September 14, 2017.
Time: 1:00 p.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C-Wing, Conference Room 6,
9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Della Hann, Ph.D.,
Director, Division of Extramural Research,
Eunice Kenney Shriver, National Institute of
Child Health and Human Development, NIH,
6710 Rockledge Blvd., MSC 7002, Bethesda,
MD 20892, 301–496–8535.
Any interested person may file written
comments with the committee by forwarding
the statement to the contact person listed on
this notice. The statement should include the
name, address, telephone number, and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles,
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
In order to facilitate public attendance at
the open session of Council in the main
meeting room, Conference Room 6, please
contact Ms. Lisa Kaeser, Program and Public
Liaison Office, NICHD, at 301–496–0536 to
make your reservation, additional seating
will be available in the meeting overflow
rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the
meeting via NIH Videocast. Please go to the
following link for Videocast access
instructions at: https://www.nichd.nih.gov/
about/advisory/nachhd/Pages/virtualmeeting.aspx.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment program, National
Institutes of Health, HHS).
VerDate Sep<11>2014
18:14 Aug 04, 2017
Jkt 241001
Dated: August 1, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16520 Filed 8–4–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; JHU Translational
Immuno-Engineering BTRC (2018/01).
Date: September 26, 2017.
Time: 09:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, 6707 Democracy
Blvd., Suite 959, Democracy Two, Bethesda,
MD 20892, (301) 451–3398, hayesj@
mail.nih.gov.
Dated: August 1, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16533 Filed 8–4–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
36807
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Pilot Clinical Trials
Targeting HIV–1 Reservoirs in Children
(U01).
Date: August 23, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: J. Bruce Sundstrom, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Rm. 3G11A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–669–5045,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 1, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16523 Filed 8–4–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\07AUN1.SGM
07AUN1
]]>Agencies
[Federal Register Volume 82, Number 150 (Monday, August 7, 2017)]
[Notices]
[Pages 36806-36807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16520]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and
Human Development (NICHD); Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Child Health and Human Development Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. A portion of this meeting will
be closed to the public in accordance with the provisions set forth in
sections
[[Page 36807]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended for the review
and discussion of grant applications. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the contact person
listed below in advance of the meeting.
Name of Committee: National Advisory Child Health and Human
Development Council.
Date: September 14, 2017.
Open: September 14, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: The agenda will include opening remarks, administrative
matters, Director's Report, Division of Extramural Research Report
and, other business of the Council.
Place: National Institutes of Health, Building 31, C-Wing,
Conference Room 6, 9000 Rockville Pike, Bethesda, MD 20892.
Closed: September 14, 2017.
Time: 1:00 p.m. to Adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C-Wing,
Conference Room 6, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Della Hann, Ph.D., Director, Division of
Extramural Research, Eunice Kenney Shriver, National Institute of
Child Health and Human Development, NIH, 6710 Rockledge Blvd., MSC
7002, Bethesda, MD 20892, 301-496-8535.
Any interested person may file written comments with the
committee by forwarding the statement to the contact person listed
on this notice. The statement should include the name, address,
telephone number, and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles, will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
In order to facilitate public attendance at the open session of
Council in the main meeting room, Conference Room 6, please contact
Ms. Lisa Kaeser, Program and Public Liaison Office, NICHD, at 301-
496-0536 to make your reservation, additional seating will be
available in the meeting overflow rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the meeting via NIH Videocast.
Please go to the following link for Videocast access instructions
at: https://www.nichd.nih.gov/about/advisory/nachhd/Pages/virtual-meeting.aspx.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment program, National
Institutes of Health, HHS).
Dated: August 1, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-16520 Filed 8-4-17; 8:45 am]
BILLING CODE 4140-01-P
